↓ Skip to main content

Heparin versus placebo for acute coronary syndromes

Overview of attention for article published in this source, April 2008
Altmetric Badge

Mentioned by

blogs
2 blogs
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
37 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heparin versus placebo for acute coronary syndromes
Published by
John Wiley & Sons, Ltd, April 2008
DOI 10.1002/14651858.cd003462.pub2
Pubmed ID
Authors

Magee, Kirk, Campbell, Samuel G, Moher, David, Rowe, Brian H

Abstract

Acute coronary syndromes (ACS) represent a spectrum of disease including unstable angina (UA) and non-ST segment myocardial infarction (NSTEMI). Despite treatment with aspirin, beta-blockers and nitroglycerin, UA/NSTEMI is still associated with significant morbidity and mortality. Although emerging evidence suggests that low molecular weight heparin (LMWH) is more efficacious compared to unfractionated heparin (UFH), there is limited data to support the role of heparins as a drug class in the treatment of ACS.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
India 1 3%
United Kingdom 1 3%
Unknown 33 89%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 6 16%
Researcher 6 16%
Student > Master 5 14%
Student > Doctoral Student 4 11%
Other 3 8%
Other 7 19%
Unknown 6 16%
Readers by discipline Count As %
Medicine and Dentistry 26 70%
Psychology 1 3%
Agricultural and Biological Sciences 1 3%
Social Sciences 1 3%
Neuroscience 1 3%
Other 0 0%
Unknown 7 19%